Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
1(7%)
Results Posted
42%(5 trials)

Phase Distribution

Ph phase_3
3
20%
Ph phase_2
2
13%
Ph not_applicable
2
13%
Ph phase_1
1
7%
Ph phase_4
7
47%

Phase Distribution

1

Early Stage

2

Mid Stage

10

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
2(13.3%)
Phase 3Large-scale testing
3(20.0%)
Phase 4Post-market surveillance
7(46.7%)
N/ANon-phased studies
2(13.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(12)
Terminated(1)
Other(1)

Detailed Status

Completed12
Active, not recruiting1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.7%)
Phase 22 (13.3%)
Phase 33 (20.0%)
Phase 47 (46.7%)
N/A2 (13.3%)

Trials by Status

active_not_recruiting17%
withdrawn17%
unknown17%
completed1280%

Recent Activity

1 active trials
Showing 5 of 15
completedphase_1

A Study of Lispro Formulations in Healthy Participants

NCT02293551
active_not_recruitingphase_2

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

NCT06238778
unknownnot_applicable

Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)

NCT05660941
completedphase_4

SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)

NCT05579119
completedphase_4

Remission Through Early Monitored Insulin Therapy - Duration Month

NCT03670641
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT02293551Phase 1

A Study of Lispro Formulations in Healthy Participants

Completed
NCT06238778Phase 2

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

Active Not Recruiting
NCT05660941Not Applicable

Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)

Unknown
NCT05579119Phase 4

SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)

Completed
NCT03670641Phase 4

Remission Through Early Monitored Insulin Therapy - Duration Month

Completed
NCT02690883Phase 4

Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy

Completed
NCT00505882Phase 4

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Withdrawn
NCT01378117Phase 4

Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

Completed
NCT02248454Not Applicable

Insulin Bolus Required for High Fat Foods in Type 1 Diabetes

Completed
NCT01110746Phase 3

To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy

Completed
NCT01000922Phase 2

A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro

Completed
NCT01159938Phase 4

A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes

Completed
NCT00279201Phase 4

The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)

Completed
NCT00046501Phase 3

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

Completed
NCT00467376Phase 3

Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15